Jeffrey Ives
Direktor/Vorstandsmitglied bei CARA THERAPEUTICS, INC.
Vermögen: 10 833 $ am 30.04.2024
Profil
Dr. Jeffrey L.
Ives is a Venture Partner at New Leaf Venture Partners LLC, an Independent Director at CARA Therapeutics, Inc., an Independent Director at Acumen Pharmaceuticals, Inc. and a Principal at Neuropharma Advisors LLC.
He is on the Board of Directors at Pinteon Therapeutics, Inc., Astrocyte Pharmaceuticals, Inc., CARA Therapeutics, Inc. and Acumen Pharmaceuticals, Inc. Dr. Ives was previously employed as a Chief Executive Officer & Director by Satori Pharmaceuticals, Inc., a Senior Vice President-Research Portfolio by Pfizer (St. Louis), a Senior Vice President by Pfizer Inc., a Director & Vice President-Business Development by Celgene Corp., and an Executive-in-Residence by Puretech Health LLC.
He received his undergraduate degree from Colgate University, a graduate degree from Yale University and a doctorate degree from Yale University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CARA THERAPEUTICS INC
0,03% | 31.03.2024 | 15 476 ( 0,03% ) | 10 833 $ | 30.04.2024 |
| 08.04.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Jeffrey Ives
| Unternehmen | Position | Beginn |
|---|---|---|
| CARA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 16.07.2014 |
| ACUMEN PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.05.2014 |
| Neuropharma Advisors LLC | Corporate Officer/Principal | 01.09.2013 |
Pinteon Therapeutics, Inc.
 Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA. | Direktor/Vorstandsmitglied | 01.10.2015 |
Astrocyte Pharmaceuticals, Inc.
 Astrocyte Pharmaceuticals, Inc. BiotechnologyHealth Technology Astrocyte Pharmaceuticals, Inc. operates as a drug development company. The firm focuses on neuroprotective strategy to protect and repair neurons that are damaged by selectively stimulating astrocytes. The company was founded by William S. Korinek and James D. Lechleiter in 2014 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 01.12.2014 |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Private Equity Investor | 01.01.2017 |
Ehemalige bekannte Positionen von Jeffrey Ives
| Unternehmen | Position | Ende |
|---|---|---|
Satori Pharmaceuticals, Inc.
 Satori Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Satori Pharmaceuticals, Inc. developed therapeutics for alzheimer's disease. The firm's drug candidates selectively modulated gamma secretase, the enzyme generating the neurotoxic peptides that form amyloid beta plaques the signature of this debilitated disease. The company was founded by Mark A. Findeis and Dennis J. Selkoe in 2005 and was headquartered in Cambridge, MA. | Vorstandsvorsitzender | 01.01.2013 |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Corporate Officer/Principal | 01.01.2007 |
| PFIZER, INC. | Corporate Officer/Principal | 01.01.2007 |
| ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
Ausbildung von Jeffrey Ives
| Yale University | Doctorate Degree |
| Colgate University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| CARA THERAPEUTICS, INC. | Health Technology |
| ACUMEN PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Finance |
Satori Pharmaceuticals, Inc.
Satori Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Satori Pharmaceuticals, Inc. developed therapeutics for alzheimer's disease. The firm's drug candidates selectively modulated gamma secretase, the enzyme generating the neurotoxic peptides that form amyloid beta plaques the signature of this debilitated disease. The company was founded by Mark A. Findeis and Dennis J. Selkoe in 2005 and was headquartered in Cambridge, MA. | Health Technology |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Health Technology |
| Neuropharma Advisors LLC | |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Pinteon Therapeutics, Inc.
Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA. | Health Technology |
Astrocyte Pharmaceuticals, Inc.
Astrocyte Pharmaceuticals, Inc. BiotechnologyHealth Technology Astrocyte Pharmaceuticals, Inc. operates as a drug development company. The firm focuses on neuroprotective strategy to protect and repair neurons that are damaged by selectively stimulating astrocytes. The company was founded by William S. Korinek and James D. Lechleiter in 2014 and is headquartered in Cambridge, MA. | Health Technology |
New Leaf Venture Partners LLC
New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Finance |
